POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,460,199 | -26.4% | 10,563,748 | 0.0% | 1.90% | -28.8% |
| Q2 2023 | $95,707,557 | +24.6% | 10,563,748 | 0.0% | 2.67% | -5.0% |
| Q1 2023 | $76,798,448 | +14.8% | 10,563,748 | +15.1% | 2.81% | -0.6% |
| Q4 2022 | $66,905,783 | +54.8% | 9,177,748 | +64.2% | 2.82% | +58.2% |
| Q3 2022 | $43,211,000 | +88.4% | 5,590,048 | +66.0% | 1.78% | +61.1% |
| Q2 2022 | $22,935,000 | -14.6% | 3,367,826 | 0.0% | 1.11% | +3.2% |
| Q1 2022 | $26,842,000 | +64.1% | 3,367,826 | +15.3% | 1.07% | +80.8% |
| Q4 2021 | $16,355,000 | -23.3% | 2,920,526 | +5.3% | 0.59% | -28.6% |
| Q3 2021 | $21,318,000 | – | 2,772,226 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,312,523 | $18,431,000 | 4.36% |
| GREAT POINT PARTNERS LLC | 2,060,000 | $16,418,000 | 3.97% |
| RA Capital Management | 9,003,018 | $71,754,000 | 1.57% |
| JOHNSON & JOHNSON | 1,000,000 | $7,970,000 | 1.51% |
| BVF INC/IL | 3,367,826 | $26,842,000 | 1.07% |
| Boxer Capital, LLC | 2,500,000 | $19,925,000 | 1.02% |
| Sio Capital Management, LLC | 377,684 | $3,010,000 | 1.00% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,014,408 | $24,025,000 | 0.73% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 204,679 | $1,631,000 | 0.68% |
| Atom Investors LP | 60,103 | $479,000 | 0.22% |